2021
DOI: 10.1089/ped.2021.0002
|View full text |Cite
|
Sign up to set email alerts
|

X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(20 citation statements)
references
References 10 publications
0
20
0
Order By: Relevance
“… 9 , 12 , 13 Two more patients have been reported to demonstrate prolonged shedding of SARS-CoV-2 virus ranging from 3 to 7 weeks, a feature seen commonly in patients with primary immunodeficiency. 7 , 10 Another case series reported 6 patients with X-linked agammaglobulinemia who had asymptomatic or mild SARS-CoV-2 infection and who promptly recovered without any specific treatment. 14 Patients with X-linked agammaglobulinemia may have milder infection because of amelioration of the cytokine storm due to impaired IL-6, IL-12 and TNF-α production and STAT1/3 upregulation through the Toll-like receptor 9 pathway.…”
Section: Discussionmentioning
confidence: 99%
“… 9 , 12 , 13 Two more patients have been reported to demonstrate prolonged shedding of SARS-CoV-2 virus ranging from 3 to 7 weeks, a feature seen commonly in patients with primary immunodeficiency. 7 , 10 Another case series reported 6 patients with X-linked agammaglobulinemia who had asymptomatic or mild SARS-CoV-2 infection and who promptly recovered without any specific treatment. 14 Patients with X-linked agammaglobulinemia may have milder infection because of amelioration of the cytokine storm due to impaired IL-6, IL-12 and TNF-α production and STAT1/3 upregulation through the Toll-like receptor 9 pathway.…”
Section: Discussionmentioning
confidence: 99%
“…These patients developed pneumonia which eventually resolved but never required ventilation or intensive care. This was the first time that B-cell response might be considered important, but it is not strictly required to overcome COVID-19 disease [ 335 , 336 ]. In addition, in 2020, groups in Germany and the USA independently discovered reactive T cells to the S glycoprotein during SARS-CoV-2 infection in around 30% of healthy donors when analyzing the T cell response of COVID-19 patients [ 337 , 338 ].…”
Section: T Cells and The Adaptive Immune System In Sars-cov-2 Researchmentioning
confidence: 99%
“…A very limited amount of data is present in the literature on SARS‐CoV‐2 infection in X‐linked agammaglobulinemia (XLA) patients 1 . Moreover, it remains unclear the role of vaccination against SARS‐CoV‐2 in these subjects 2 …”
Section: Figurementioning
confidence: 99%
“…To the Editor, A very limited amount of data is present in the literature on SARS-CoV-2 infection in X-linked agammaglobulinemia (XLA) patients. 1 Moreover, it remains unclear the role of vaccination against SARS-CoV-2 in these subjects. 2 IL-6 is the main cause of the cytokine storm 3 that characterized severe COVID-19; notably, the lack of IL-6 production by macrophages due to the absence of Bruton tyrosine kinase (BTK) that characterized XLA patients was suggested to be responsible for the mild-to-moderate clinical course of infection seen in these patients.…”
mentioning
confidence: 99%